Last reviewed · How we verify
Atelectasis due to Mucous Obstruction
Approved treatments
- Acetadote · University of Texas Southwestern Medical Center
- Acetadote · Bristol-Myers Squibb
Acetylcysteine reduces liver injury from acetaminophen overdose by maintaining glutathione levels or providing alternate conjugation substrate. - Acetylcystein · University Hospital, Strasbourg, France
- L-cysteine · Louisiana State University Health Sciences Center Shreveport
- Cysteine Hydrochloride · Exela Pharma
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Atelectasis due to Mucous Obstruction patent landscape — cliff calendar, originator estates, attackable patents
- Atelectasis due to Mucous Obstruction treatment landscape brief
- Atelectasis due to Mucous Obstruction treatment updates RSS
Frequently asked questions about Atelectasis due to Mucous Obstruction
What drugs treat Atelectasis due to Mucous Obstruction?
Tracked treatments include Acetadote, Acetylcystein, L-cysteine, Cysteine Hydrochloride.
What is the treatment for Atelectasis due to Mucous Obstruction?
Standard treatment for Atelectasis due to Mucous Obstruction includes Acetadote, Acetylcystein, L-cysteine, Cysteine Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Atelectasis due to Mucous Obstruction patent cliff · Atelectasis due to Mucous Obstruction CI report
- Treatment: Acetadote · University of Texas Southwestern Medical Center
- Treatment: Acetadote · Bristol-Myers Squibb
- Treatment: Acetylcystein · University Hospital, Strasbourg, France
- Treatment: L-cysteine · Louisiana State University Health Sciences Center Shreveport
- Treatment: Cysteine Hydrochloride · Exela Pharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing